Role of potassium channels in hypoxic chemoreception in rat carotid body type-I cells.
Buckler
K J
KJ
University Laboratory of Physiology, Oxford, UK.
D015761:4-Aminopyridine / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D002344:Carotid Body / Q000166:cytology / Q000187:drug effects / Q000503:physiopathology*; D018999:Charybdotoxin / Q000494:pharmacology; D000860:Hypoxia / Q000503:physiopathology*; D015640:Ion Channel Gating / Q000187:drug effects / Q000502:physiology; D017136:Ion Transport / Q000187:drug effects; D008564:Membrane Potentials / Q000187:drug effects; D009419:Nerve Tissue Proteins / Q000502:physiology*; D010100:Oxygen / Q000097:blood; D011188:Potassium / Q000378:metabolism*; D015221:Potassium Channels / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D019789:Tetraethylammonium; D013757:Tetraethylammonium Compounds / Q000494:pharmacology
D009419:Nerve Tissue Proteins; D015221:Potassium Channels; D013757:Tetraethylammonium Compounds; D018999:Charybdotoxin; D019789:Tetraethylammonium; D015761:4-Aminopyridine; D011188:Potassium; D010100:Oxygen